IRIS - Res&Arch Institutional Research Information System - Research & Archive

BELLOMO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 954
NA - Nord America 949
EU - Europa 506
SA - Sud America 175
AF - Africa 26
OC - Oceania 6
Totale 2.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 923
SG - Singapore 428
CN - Cina 148
HK - Hong Kong 137
BR - Brasile 131
IT - Italia 120
RU - Federazione Russa 87
VN - Vietnam 65
DE - Germania 63
IE - Irlanda 58
KR - Corea 48
FR - Francia 41
FI - Finlandia 27
GB - Regno Unito 27
IN - India 24
BD - Bangladesh 19
JP - Giappone 19
NL - Olanda 18
CA - Canada 17
AR - Argentina 14
IQ - Iraq 13
RO - Romania 12
TR - Turchia 11
PL - Polonia 10
VE - Venezuela 10
ZA - Sudafrica 9
AT - Austria 7
ES - Italia 7
SE - Svezia 6
EC - Ecuador 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
ID - Indonesia 4
PK - Pakistan 4
PY - Paraguay 4
TN - Tunisia 4
LT - Lituania 3
MX - Messico 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
RE - Reunion 1
SD - Sudan 1
SN - Senegal 1
TJ - Tagikistan 1
TW - Taiwan 1
UA - Ucraina 1
ZM - Zambia 1
Totale 2.616
Salva come PNG Salva come JPEG
Città #
Singapore 318
San Jose 140
Hong Kong 136
Ashburn 94
Chandler 83
Dublin 58
Boardman 57
Seoul 48
Los Angeles 40
Perugia 37
Moscow 35
Santa Clara 34
Lauterbourg 32
The Dalles 31
Beijing 30
Piscataway 24
Munich 23
New York 21
Ho Chi Minh City 19
San Mateo 18
Tokyo 18
Hanoi 14
São Paulo 14
Altamura 12
Dallas 12
Milan 12
Brooklyn 11
Helsinki 11
Nuremberg 11
Turku 11
Timisoara 10
Chennai 9
Lawrence 9
Medford 9
Princeton 9
Rome 9
Wilmington 9
Warsaw 8
Da Nang 7
Denver 7
Hefei 7
Montreal 7
Amsterdam 6
Boston 6
Council Bluffs 6
Frankfurt am Main 6
Houston 6
London 6
Orem 6
Phoenix 6
Redmond 6
Andover 5
Atlanta 5
Auckland 5
Baghdad 5
Columbus 5
Dong Ket 5
Falkenstein 5
Falls Church 5
Lappeenranta 5
Manchester 5
Poplar 5
Stockholm 5
Vienna 5
Curitiba 4
Johannesburg 4
Rio de Janeiro 4
Secaucus 4
Caracas 3
Charlotte 3
Chicago 3
Des Moines 3
Groningen 3
Mumbai 3
Newark 3
Newquay 3
Shanghai 3
Tashkent 3
Toronto 3
Turin 3
Al Hillah 2
Ankara 2
Baku 2
Belém 2
Betim 2
Brasília 2
Brixen 2
City of London 2
Córdoba 2
Exeter 2
Florence 2
Fortaleza 2
Genoa 2
Goiânia 2
Guangzhou 2
Haiphong 2
Istanbul 2
João Pessoa 2
Lahore 2
Las Vegas 2
Totale 1.715
Salva come PNG Salva come JPEG
Nome #
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 145
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 125
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 112
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 108
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 96
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 93
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 82
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 80
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 79
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 78
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 78
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 76
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 75
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 75
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 74
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 71
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 71
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 71
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 66
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 66
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 66
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 66
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 64
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 59
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 59
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 58
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 58
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 57
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 57
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 55
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 54
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 53
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 49
Research advancement in fluid biomarkers for Parkinson's disease 45
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? 42
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 31
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function 16
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 15
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 13
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 13
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 11
Totale 2.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 3 7
2021/202264 1 10 2 0 2 5 4 13 4 7 7 9
2022/2023259 9 60 8 17 19 22 0 20 91 1 8 4
2023/2024223 10 16 12 6 7 1 34 6 49 11 27 44
2024/2025680 7 55 51 37 54 44 55 66 115 43 101 52
2025/20261.403 95 119 62 197 208 131 252 77 146 116 0 0
Totale 2.662